InvestorsHub Logo
Followers 8
Posts 2073
Boards Moderated 0
Alias Born 04/23/2018

Re: None

Sunday, 12/13/2020 7:52:28 AM

Sunday, December 13, 2020 7:52:28 AM

Post# of 286
EMA Committee Recommends Approval for Seagen's Tukysa in Advanced HER2-Positive Breast Cancer

https://www.precisiononcologynews.com/regulatory-news-fda-approvals/ema-committee-recommends-approval-seagens-tukysa-advanced-her2#.X9YNotHYq3A